Sec Form 13D Filing - Saba Capital Management L.P. filing for Nuveen Real Asset Income & Growth Fund (JRI) - 2024-01-18

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A

 

Under the Securities Exchange Act of 1934

(Amendment No. 4)*

 

Nuveen Real Asset Income & Growth Fund

(Name of Issuer)

 

Common Shares, $0.01 par value

(Title of Class of Securities)

 

67074Y105

(CUSIP Number)

Saba Capital Management, L.P.

405 Lexington Avenue

58th Floor

New York, NY 10174

Attention: Michael D'Angelo

(212) 542-4635
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

January 16, 2024

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [ ]

(Page 1 of 8 Pages)

______________________________

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No.  67074Y105 SCHEDULE 13D/A Page 2 of 8 Pages

1 NAME OF REPORTING PERSON
     Saba Capital Management, L.P.
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐
(b) ☐
3 SEC USE ONLY

4 SOURCE OF FUNDS
     OO (see Item 3)
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6 CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
7 SOLE VOTING POWER
     -0-
8 SHARED VOTING POWER
     2,498,743
9 SOLE DISPOSITIVE POWER
     -0-
10 SHARED DISPOSITIVE POWER
     2,498,743
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
     2,498,743
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     9.11%
14 TYPE OF REPORTING PERSON
     PN; IA
       

The percentages used herein are calculated based upon 27,416,679 shares of common stock outstanding as of 6/30/23, as disclosed in the company's N-CSRS filed 9/6/23


CUSIP No.  67074Y105 SCHEDULE 13D/A Page 3 of 8 Pages

1 NAME OF REPORTING PERSON
     Boaz R. Weinstein
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐
(b) ☐
3 SEC USE ONLY

4 SOURCE OF FUNDS
     OO (see Item 3)
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6 CITIZENSHIP OR PLACE OF ORGANIZATION
     United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
7 SOLE VOTING POWER
     -0-
8 SHARED VOTING POWER
     2,498,743
9 SOLE DISPOSITIVE POWER
     -0-
10 SHARED DISPOSITIVE POWER
     2,498,743
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
     2,498,743
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     9.11%
14 TYPE OF REPORTING PERSON
     IN
       

The percentages used herein are calculated based upon 27,416,679 shares of common stock outstanding as of 6/30/23, as disclosed in the company's N-CSRS filed 9/6/23


CUSIP No.  67074Y105 SCHEDULE 13D/A Page 4 of 8 Pages

1 NAME OF REPORTING PERSON
     Saba Capital Management GP, LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ☐
(b) ☐
3 SEC USE ONLY

4 SOURCE OF FUNDS
     OO (see Item 3)
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

6 CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
7 SOLE VOTING POWER
     -0-
8 SHARED VOTING POWER
     2,498,743
9 SOLE DISPOSITIVE POWER
     -0-
10 SHARED DISPOSITIVE POWER
     2,498,743
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON
     2,498,743
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     9.11%
14 TYPE OF REPORTING PERSON
     OO
       

The percentages used herein are calculated based upon 27,416,679 shares of common stock outstanding as of 6/30/23, as disclosed in the company's N-CSRS filed 9/6/23


CUSIP No.  67074Y105 SCHEDULE 13D/A Page 5 of 8 Pages

Item 1.

SECURITY AND ISSUER

 

 

 

This Amendment No. 4 amends and supplements the statement on Schedule 13D filed with the SEC on 8/14/23, as amended by Amendment No.1 filed 9/29/23, Amendment No.2 filed 11/10/23 and Amendment No.3 filed 12/5/23; with respect to the common shares of Nuveen Real Asset Income & Growth Fund. This Amendment No. 4 amends Items 3, 4, 5, 6 and 7, as set forth below.


Item 3.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

 

 

 

Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business.  In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time.  Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $28,002,150 was paid to acquire the Common Shares reported herein.


Item 4.

PURPOSE OF TRANSACTION

 

 

 

On January 16, 2024, Saba Capital Master Fund, Ltd., a private fund advised by Saba Capital, submitted to the Issuer a notice of intent informing the Issuer of its intention to nominate Jason Chen (the "Nominee") as an independent trustee for election to the Board at the Issuer's 2024 annual meeting of shareholders. 

The Nominee has entered into a nomination agreement (the "Nominee Agreement") with Saba Capital substantially in the form attached as Exhibit 3 to this Schedule 13D/A whereby the Nominee agreed to stand for election as a trustee of the Issuer in connection with a proxy solicitation which may be conducted in respect of the 2024 Annual Meeting and whereby, Saba Capital has agreed to defend and indemnify the Nominee against, and with respect to, any losses that may be incurred by the Nominee in the event he becomes a party to litigation based on his nomination as a candidate for election to the Board and the solicitation of proxies in support of his election. The foregoing summary of the Nominee Agreement is not complete and is qualified in its entirety by reference to the full text of the form of Nominee Agreement, a copy of which is attached as Exhibit 3 and is incorporated by reference herein.


Item 5.

INTEREST IN SECURITIES OF THE ISSUER

 

 

(a)

See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons.  The percentages used herein are calculated based upon 27,416,679 shares of common stock outstanding as of 6/30/23, as disclosed in the company's N-CSRS filed 9/6/23



CUSIP No.  67074Y105 SCHEDULE 13D/A Page 6 of 8 Pages

(b)

See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

 

 

(c)

The transactions in the Common Shares effected since the Schedule 13D/A filing on 12/5/23 by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference.

 

 

(d)

The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares.

 

 

(e)

Not applicable.

 

 

Item 6.

CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER

 

 

 

Item 6 is hereby amended and supplemented by the addition of the following:

 

 

 

The Reporting Persons' response to Item 4 is incorporated by reference into this Item 6.


Item 7.

MATERIAL TO BE FILED AS EXHIBITS

 

 

Exhibit 3:

Form of Nominee Agreement



CUSIP No.  67074Y105 SCHEDULE 13D/A Page 7 of 8 Pages

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date:  January 18, 2024

 

SABA CAPITAL MANAGEMENT, L.P. 

By:  /s/ Michael D'Angelo

 

Name: Michael D'Angelo

Title: Chief Compliance Officer

 

 

 

 

 

SABA CAPITAL MANAGEMENT GP, LLC 

By:  /s/ Michael D'Angelo

Name: Michael D'Angelo

Title: Authorized Signatory

 

 

 

 

 

BOAZ R. WEINSTEIN 

By:  /s/ Michael D'Angelo

 

Name: Michael D'Angelo

 

Title: Attorney-in-fact*

 

* Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 

 



CUSIP No.  67074Y105 SCHEDULE 13D/A Page 8 of 8 Pages

Schedule A

This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 12/5/23.  All transactions were effectuated in the open market through a broker.

Trade Date

Buy/Sell

Shares

Price

12/5/2023

Buy

1,519

11.24

12/6/2023

Buy

7,884

11.33

12/12/2023

Buy

3,366

11.32

12/14/2023

Buy

22,368

11.85

1/2/2024

Buy

6,110

11.78

1/3/2024

Buy

22,971

11.87

1/4/2024

Buy

34,143

11.94

1/8/2024

Sell

(38,623)

11.93

1/16/2024

Buy

12,657

11.69